A citation-based method for searching scientific literature

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Asanao Shimokawa, Hirokazu Takami, Shota Tanaka, Akitake Mukasa, Mitsuaki Shirahata, Saki Shimizu, Kaori Suzuki, Kuniaki Saito, Keiichi Kobayashi, Fumi Higuchi, Takeo Uzuka, Ryohei Otani, Kaoru Tamura, Kazutaka Sumita, Makoto Ohno, Yasuji Miyakita, Naoki Kagawa, Naoya Hashimoto, Ryusuke Hatae, Koji Yoshimoto, Naoki Shinojima, Hideo Nakamura, Yonehiro Kanemura, Yoshiko Okita, Manabu Kinoshita, Kenichi Ishibashi, Tomoko Shofuda, Yoshinori Kodama, Kanji Mori, Yusuke Tomogane, Junya Fukai, Koji Fujita, Yuzo Terakawa, Naohiro Tsuyuguchi, Shusuke Moriuchi, Masahiro Nonaka, Hiroyoshi Suzuki, Makoto Shibuya, Taketoshi Maehara, Nobuhito Saito, Motoo Nagane, Nobutaka Kawahara, Keisuke Ueki, Toshiki Yoshimine, Etsuo Miyaoka, Ryo Nishikawa, Takashi Komori, Yoshitaka Narita, Koichi Ichimura. Acta Neuropathol Commun 2016
Times Cited: 116



Michele Ceccarelli, Floris P Barthel, Tathiane M Malta, Thais S Sabedot, Sofie R Salama, Bradley A Murray, Olena Morozova, Yulia Newton, Amie Radenbaugh, Stefano M Pagnotta, Samreen Anjum, Jiguang Wang, Ganiraju Manyam, Pietro Zoppoli, Shiyun Ling, Arjun A Rao, Mia Grifford, Andrew D Cherniack, Hailei Zhang, Laila Poisson, Carlos Gilberto Carlotti, Daniela Pretti da Cunha Tirapelli, Arvind Rao, Tom Mikkelsen, Ching C Lau, W K Alfred Yung, Raul Rabadan, Jason Huse, Daniel J Brat, Norman L Lehman, Jill S Barnholtz-Sloan, Siyuan Zheng, Kenneth Hess, Ganesh Rao, Matthew Meyerson, Rameen Beroukhim, Lee Cooper, Rehan Akbani, Margaret Wrensch, David Haussler, Kenneth D Aldape, Peter W Laird, David H Gutmann, Houtan Noushmehr, Antonio Iavarone, Roel G W Verhaak. Cell 2016
Times Cited: 942




List of shared articles



Times cited

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas.
Manabu Kinoshita, Hideyuki Arita, Masamichi Takahashi, Takehiro Uda, Junya Fukai, Kenichi Ishibashi, Noriyuki Kijima, Ryuichi Hirayama, Mio Sakai, Atsuko Arisawa,[...]. Front Oncol 2021
1

The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies.
Evrysthenis Vartholomatos, George Vartholomatos, George A Alexiou, Georgios S Markopoulos. Methods Protoc 2021
1

Telomerase reverse transcriptase promoter mutation- and O6-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?
Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, Marietta Wolter, Gabriele Schackert, Manfred Westphal, Luca Regli, Niklas Thon, Marcos Tatagiba, Wolfgang Wick,[...]. Eur J Cancer 2021
0

TERT Promoter Alterations in Glioblastoma: A Systematic Review.
Nathalie Olympios, Vianney Gilard, Florent Marguet, Florian Clatot, Frédéric Di Fiore, Maxime Fontanilles. Cancers (Basel) 2021
0

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi, Kai Yamasaki, Yuko Matsushita, Taishi Nakamura, Yasuji Miyakita, Toru Umehara, Keiichi Kobayashi, Kaoru Tamura,[...]. Acta Neuropathol 2021
3

Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA.
Yasuhide Makino, Yoshiki Arakawa, Ema Yoshioka, Tomoko Shofuda, Takeshi Kawauchi, Yukinori Terada, Masahiro Tanji, Daisuke Kanematsu, Yohei Mineharu, Susumu Miyamoto,[...]. Sci Rep 2021
0

Assessing Versatile Machine Learning Models for Glioma Radiogenomic Studies across Hospitals.
Risa K Kawaguchi, Masamichi Takahashi, Mototaka Miyake, Manabu Kinoshita, Satoshi Takahashi, Koichi Ichimura, Ryuji Hamamoto, Yoshitaka Narita, Jun Sese. Cancers (Basel) 2021
1


Infrequent RAS mutation is not associated with specific histological phenotype in gliomas.
Yasuhide Makino, Yoshiki Arakawa, Ema Yoshioka, Tomoko Shofuda, Sachiko Minamiguchi, Takeshi Kawauchi, Masahiro Tanji, Daisuke Kanematsu, Masahiro Nonaka, Yoshiko Okita,[...]. BMC Cancer 2021
0

Is There an Independent Role of TERT and NF1 in High Grade Gliomas?
Evangelia Razis, Vassiliki Kotoula, Georgia-Angeliki Koliou, Kyriaki Papadopoulou, Eleni Vrettou, Eleni Giannoulatou, Ioannis Tikas, Stefanos V Labropoulos, Georgios Rigakos, Styliani Papaemmanoyil,[...]. Transl Oncol 2020
5

Retrospective clinical trial experimentally validates glioblastoma genome-wide pattern of DNA copy-number alterations predictor of survival.
Sri Priya Ponnapalli, Matthew W Bradley, Karen Devine, Jay Bowen, Sara E Coppens, Kristen M Leraas, Brett A Milash, Fuqiang Li, Huijuan Luo, Shi Qiu,[...]. APL Bioeng 2020
1


The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis.
Huy Gia Vuong, Thu Quynh Nguyen, Tam N M Ngo, Hoang Cong Nguyen, Kar-Ming Fung, Ian F Dunn. BMC Cancer 2020
2

Prognostic significance of genetic biomarkers in isocitrate dehydrogenase-wild-type lower-grade glioma: the need to further stratify this tumor entity - a meta-analysis.
H G Vuong, T T K Tran, H T T Ngo, T Q Pham, T Nakazawa, K-M Fung, L Hassell, R Katoh, T Kondo. Eur J Neurol 2019
8

Integrating a Large Next-Generation Sequencing Panel into the Clinical Diagnosis of Gliomas Provides a Comprehensive Platform for Classification from FFPE Tissue or Smear Preparations.
Megan Parilla, Sabah Kadri, Sushant A Patil, Carrie Fitzpatrick, Lauren Ritterhouse, Jeremy Segal, John Collins, Peter Pytel. J Neuropathol Exp Neurol 2019
10

Sequencing and curation strategies for identifying candidate glioblastoma treatments.
Mayu O Frank, Takahiko Koyama, Kahn Rhrissorrakrai, Nicolas Robine, Filippo Utro, Anne-Katrin Emde, Bo-Juen Chen, Kanika Arora, Minita Shah, Heather Geiger,[...]. BMC Med Genomics 2019
4

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts.
Toru Umehara, Hideyuki Arita, Ema Yoshioka, Tomoko Shofuda, Daisuke Kanematsu, Manabu Kinoshita, Yoshinori Kodama, Masayuki Mano, Naoki Kagawa, Yasunori Fujimoto,[...]. Acta Neuropathol Commun 2019
16

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas.
Ivana Jovčevska, Alja Zottel, Neja Šamec, Jernej Mlakar, Maxim Sorokin, Daniil Nikitin, Anton A Buzdin, Radovan Komel. Cancers (Basel) 2019
7

Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Tobias Kessler, Felix Sahm, Ahmed Sadik, Damian Stichel, Anne Hertenstein, Guido Reifenberger, Angela Zacher, Michael Sabel, Ghazaleh Tabatabai, Joachim Steinbach,[...]. Neuro Oncol 2018
32

BRAF V600E, TERT promoter mutations and CDKN2A/B homozygous deletions are frequent in epithelioid glioblastomas: a histological and molecular analysis focusing on intratumoral heterogeneity.
Nozomi Nakajima, Sumihito Nobusawa, Satoshi Nakata, Mitsutoshi Nakada, Tatsuya Yamazaki, Nozomi Matsumura, Kenichi Harada, Hadzki Matsuda, Nobuaki Funata, Shoichi Nagai,[...]. Brain Pathol 2018
25

When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM.
Saumya R Bollam, Michael E Berens, Harshil D Dhruv. Curr Neurol Neurosci Rep 2018
3

Molecular classification of adult gliomas: recent advances and future perspectives.
Marc Barritault, David Meyronet, François Ducray. Curr Opin Oncol 2018
2

cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
Daniel J Brat, Kenneth Aldape, Howard Colman, Eric C Holland, David N Louis, Robert B Jenkins, B K Kleinschmidt-DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp,[...]. Acta Neuropathol 2018
263